Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000563923 | SCV000668215 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000563923 | SCV000912151 | likely benign | Hereditary cancer-predisposing syndrome | 2017-04-07 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001063014 | SCV001227844 | uncertain significance | Familial cancer of breast | 2023-06-14 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 482789). This variant has not been reported in the literature in individuals affected with BARD1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 130 of the BARD1 protein (p.Lys130Thr). |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002265803 | SCV002548032 | uncertain significance | not specified | 2022-05-30 | criteria provided, single submitter | clinical testing |